z-logo
open-access-imgOpen Access
Treatment of Helicobacter pylori Infection
Author(s) -
Julio Salcedo,
Firas AlKawas
Publication year - 1998
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.158.8.842
Subject(s) - helicobacter pylori , tolerability , medicine , peptic ulcer , helicobacter pylori infection , disease , drug , peptic , helicobacter infections , intensive care medicine , gastroenterology , pharmacology , adverse effect
Since acceptance of the association between Helicobacter pylori and peptic ulcer disease, eradication of H. pylori has become the standard of care in the treatment of peptic ulcer disease. Unfortunately, eradication therapy is no easy task, especially when one is faced with a myriad of drug combinations with varying degrees of efficacy and tolerability. The following is a review of the literature regarding the drugs and drug combinations used to eradicate H. pylori and their effectiveness both as single agents and in combination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom